+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Carrier Screening Market - Global Forecast 2026-2032- Product Image
Carrier Screening Market - Global Forecast 2026-2032- Product Image
Sale

Carrier Screening Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995397
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Carrier Screening Market is projected to reach USD 3.49 Billion in 2026. It is expected to continue growing at a CAGR of 5.95%, reaching USD 4.97 Billion by 2032.

Carrier screening is moving from a niche prenatal test to a mainstream component of reproductive health, preconception planning, infertility care, and population genomics. The field is anchored in clinically established testing for autosomal recessive and X-linked conditions, with professional guidance from the American College of Obstetricians and Gynecologists and the American College of Medical Genetics and Genomics supporting informed, voluntary screening before or during pregnancy.

Demand is being shaped by next-generation sequencing, expanded carrier screening panels, digital genetic counseling workflows, and broader awareness of inherited disease risk. For laboratories, health systems, payers, and fertility networks, the strategic priority is no longer only test availability; it is delivering accurate variant interpretation, equitable access, responsible consent, and actionable results that fit within clinical decision-making.

Transformative Shifts in the Carrier Screening Landscape

The carrier screening landscape is being transformed by the shift from ancestry-based testing to pan-ethnic and expanded carrier screening models. This change reflects the limitations of relying solely on self-reported ethnicity in increasingly diverse populations and aligns with professional recommendations that emphasize consistent, patient-centered access to screening.

Technology is also reshaping competition. Sequencing-based panels can evaluate many genes in a single workflow, while improved bioinformatics, curated variant databases, and laboratory automation support faster turnaround and scalable testing. At the same time, the field is facing greater scrutiny around residual risk communication, variants of uncertain significance, reproductive autonomy, and the need for qualified genetic counseling.

Commercial success increasingly depends on integrating carrier screening into obstetrics, reproductive endocrinology, IVF, donor gamete programs, and primary care. Providers that can pair clinical-grade testing with clear reporting, payer-ready evidence, and culturally competent education are best positioned to gain trust.

Cumulative Impact of Artificial Intelligence on Carrier Screening

Artificial intelligence is creating a cumulative impact across the carrier screening value chain by improving literature surveillance, variant triage, quality control, report generation, and operational efficiency. AI-enabled tools can help laboratories prioritize evidence from ClinVar, population databases, and peer-reviewed literature, but clinically responsible interpretation still requires expert review under established ACMG/AMP variant classification principles.

In patient-facing workflows, AI-supported intake, risk education, and scheduling can reduce administrative burden and improve access to genetic counseling. However, carrier screening involves reproductive decisions, so AI must be implemented with strong governance, auditability, bias monitoring, privacy protection, and transparent escalation to licensed professionals.

The near-term opportunity is not autonomous decision-making; it is augmented precision. Organizations that use AI to standardize workflows, identify documentation gaps, support multilingual education, and accelerate compliant reporting can improve both scalability and patient experience while preserving clinical accountability.

Key Regional Insights Across Global Carrier Screening Markets

North America remains one of the most mature regions for carrier screening due to established obstetric practice, broad availability of CLIA-certified laboratories in the United States, advanced payer contracting, and significant use of expanded carrier screening in fertility care. Canada shows steady adoption through specialist-led genetics services and provincial health system considerations, with ongoing emphasis on evidence-based coverage and equitable access.

Europe is characterized by strong regulatory oversight, public health ethics, and country-specific reimbursement pathways. The European Union’s medical device regulation and data protection framework influence how laboratories validate tests, manage patient data, and market genetic services. The United Kingdom, Germany, France, Italy, and Spain show varied adoption based on national screening policies, clinical genetics capacity, and public-private care structures.

Asia-Pacific is supported by rising maternal health investment, expanding sequencing infrastructure, and increasing demand for reproductive planning in China, India, Japan, South Korea, and Australia. Latin America, led by Brazil and Mexico, is advancing through private healthcare networks and specialty fertility centers, although affordability and access remain constraints. The Middle East is notable for higher awareness of consanguinity-related recessive disease risk in several countries, particularly across GCC markets, while Africa presents long-term potential as genomic medicine capacity, newborn health programs, and laboratory infrastructure develop.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are gaining relevance as private hospital groups, fertility clinics, and regional laboratory networks expand access to genetic testing in urban centers. Adoption is strongest where maternal health services, medical tourism, and sequencing partnerships are developing, although reimbursement and genetics workforce capacity remain uneven.

The GCC is a strategically important group for carrier screening because several member states have invested in premarital and preventive genetic health programs, reflecting the regional burden of inherited disorders and the public health value of early risk identification. In the European Union, adoption is shaped by harmonized regulatory expectations, data privacy requirements, national health technology assessment processes, and established public health ethics.

BRICS countries combine large birth cohorts, rising middle-class healthcare demand, and expanding domestic genomics capabilities, making them important for broader carrier screening adoption. G7 markets generally lead in clinical adoption, evidence generation, reimbursement sophistication, and laboratory quality standards. NATO countries overlap with many advanced healthcare systems, where resilience of diagnostics supply chains, cybersecurity, and cross-border data governance increasingly influence genetic testing infrastructure.

Key Country Insights for Carrier Screening Adoption

The United States leads carrier screening commercialization through broad laboratory competition, advanced reproductive medicine networks, and established professional guidance, while Canada emphasizes specialist genetics pathways and public health evaluation. Mexico and Brazil are developing through private-sector diagnostics, fertility clinics, and growing awareness of inherited disease prevention.

In Europe, the United Kingdom benefits from strong genomics policy infrastructure and the National Health Service’s experience in genetic medicine. Germany and France prioritize clinical validity, reimbursement discipline, and data protection, while Italy and Spain show demand through obstetric and fertility channels. Russia has scientific and clinical genetics capacity, although adoption is shaped by regulatory and geopolitical constraints.

China is scaling genomic testing through domestic sequencing capabilities and large healthcare demand, while India offers major long-term potential due to population size, expanding private diagnostics, and rising reproductive health awareness. Japan, South Korea, and Australia show high-quality clinical infrastructure, strong laboratory standards, and growing use of carrier screening in fertility and preconception care.

Actionable Recommendations for Carrier Screening Industry Leaders

Industry leaders should prioritize clinically validated expanded carrier screening panels that align with professional guidance, clearly communicate residual risk, and minimize unnecessary reporting of uncertain findings. Test menus should be designed around actionability, disease severity, analytical validity, and relevance across diverse populations.

Laboratories and health systems should invest in genetic counseling capacity, digital education, multilingual patient materials, and EHR-integrated ordering and reporting. Payer engagement should focus on evidence that screening supports informed reproductive decision-making, reduces diagnostic uncertainty, and improves care coordination.

Commercial teams should build partnerships with obstetricians, reproductive endocrinologists, IVF centers, donor programs, and public health stakeholders. Operationally, leaders must strengthen quality systems, cybersecurity, data governance, AI oversight, and compliance with regional regulations such as HIPAA, GDPR, CLIA, CAP, and applicable medical device requirements.

Research Methodology for Carrier Screening Market Intelligence

This executive summary is built on a structured research methodology combining secondary research, expert interpretation, and market triangulation. Verified sources include professional society guidance, peer-reviewed genetics literature, regulatory frameworks, public health agencies, laboratory quality standards, and healthcare policy documentation from recognized institutions.

The analysis evaluates carrier screening across technology platforms, clinical use cases, regional adoption patterns, reimbursement environments, competitive dynamics, and emerging digital tools. Insights are cross-checked against established medical genetics principles, including ACMG/AMP variant interpretation standards, ACOG carrier screening recommendations, and widely used laboratory accreditation expectations.

The research approach distinguishes observed market drivers from speculative claims. Findings are synthesized to support executive decision-making for diagnostics companies, life sciences investors, healthcare providers, payers, and policy stakeholders.

Conclusion: The Future of Carrier Screening

Carrier screening is becoming a foundational element of precision reproductive healthcare. The field is supported by expanding sequencing capacity, broader clinical awareness, and a shift toward equitable, pan-ethnic screening models that better reflect modern population diversity.

The next phase of development will be defined by clinical trust. Organizations that combine high-quality laboratory science with responsible AI, clear counseling pathways, payer-relevant evidence, and strong data governance will be best positioned to scale. As reproductive health systems increasingly value prevention, informed choice, and early risk identification, carrier screening will remain a strategically important diagnostics category worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Carrier Screening Market, by Test Type
7.1. Introduction
7.2. Expanded Carrier Panel
7.3. Single Gene Test
7.4. Targeted Carrier Panel
8. Carrier Screening Market, by Technology
8.1. Introduction
8.2. Microarray
8.3. Next Generation Sequencing
8.3.1. Targeted Sequencing
8.3.2. Whole Exome Sequencing
8.4. Polymerase Chain Reaction
8.4.1. Digital PCR
8.4.2. Quantitative PCR
8.5. Sanger Sequencing
9. Carrier Screening Market, by Carrier Type
9.1. Introduction
9.2. Autosomal Recessive Disorders
9.3. X Linked Disorders
10. Carrier Screening Market, by Application
10.1. Introduction
10.2. Reproductive Planning
10.2.1. Preconception Counseling
10.2.2. Family Planning Decisions
10.3. Prenatal Risk Assessment
10.4. Assisted Reproductive Technology (ART)
10.4.1. Embryo Selection Support
10.4.2. Preimplantation Genetic Testing Support
10.5. Population Screening
11. Carrier Screening Market, by End User
11.1. Introduction
11.2. Hospital Laboratories
11.3. Independent Laboratories
11.4. Specialty Clinics
12. Carrier Screening Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Carrier Screening Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Carrier Screening Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 23Andme Inc.
16.2. Abbott Laboratories
16.3. Ambry Genetics Corporation by Konica Minolta, Inc.
16.4. Asper Biogene
16.5. Autogenomics Inc. by Prescient Medicine Holdings Inc.
16.6. BGI Genomics Co., Ltd.
16.7. Biora Therapeutics, Inc.
16.8. CENTOGENE N.V.
16.9. Danaher Corporation
16.10. Eurofins Scientific
16.11. F. Hoffmann-La Roche Ltd.
16.12. Fulgent Genetics, Inc.
16.13. Gene by Gene, Ltd. by myDNA Inc.
16.14. GeneDx Holdings Corp.
16.15. Illumina Inc.
16.16. Invitae Corporation
16.17. Laboratory Corporation of America Holdings
16.18. Luminex Corporation by DiaSorin Company
16.19. MedGenome Labs Ltd.
16.20. Myriad Genetics, Inc.
16.21. Natera, Inc.
16.22. OPKO Health, Inc.
16.23. Otogenetics Corporation
16.24. Quest Diagnostics Inc.
16.25. Thermo Fisher Scientific Inc.
16.26. TRUE HEALTH LABS
17. Key Experts
List of Figures
FIGURE 1. Global Carrier Screening Market, Years Considered for the Study
FIGURE 2. Global Carrier Screening Market, Research Design
FIGURE 3. Global Carrier Screening Market, Research Framework
FIGURE 4. Global Carrier Screening Market, Data Triangulation
FIGURE 5. Global Carrier Screening Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Carrier Screening Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 7. Global Carrier Screening Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Carrier Screening Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Carrier Screening Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Carrier Screening Market Size, by Carrier Type, 2025 vs 2032 (%)
FIGURE 11. Global Carrier Screening Market Size, by Carrier Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Carrier Screening Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Carrier Screening Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Carrier Screening Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Carrier Screening Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Carrier Screening Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Carrier Screening Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Carrier Screening Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Carrier Screening Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Carrier Screening Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Carrier Screening Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Carrier Screening Market Segmentation & Coverage
TABLE 2. Global Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 3. Global Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 4. Global Expanded Carrier Panel Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Expanded Carrier Panel Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Expanded Carrier Panel Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Single Gene Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Single Gene Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Single Gene Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Targeted Carrier Panel Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Targeted Carrier Panel Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Targeted Carrier Panel Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 14. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Whole Exome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Whole Exome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Whole Exome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Quantitative PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Quantitative PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Quantitative PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Sanger Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Sanger Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Sanger Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 39. Global Autosomal Recessive Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Autosomal Recessive Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Autosomal Recessive Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global X Linked Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global X Linked Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global X Linked Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 46. Global Reproductive Planning Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Reproductive Planning Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Reproductive Planning Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Preconception Counseling Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Preconception Counseling Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Preconception Counseling Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Family Planning Decisions Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Family Planning Decisions Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Family Planning Decisions Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Prenatal Risk Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Prenatal Risk Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Prenatal Risk Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Assisted Reproductive Technology (ART) Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Assisted Reproductive Technology (ART) Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Assisted Reproductive Technology (ART) Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Embryo Selection Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Embryo Selection Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Embryo Selection Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Preimplantation Genetic Testing Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Preimplantation Genetic Testing Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Preimplantation Genetic Testing Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Population Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Population Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Population Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Global Hospital Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Hospital Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Hospital Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Independent Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Independent Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Independent Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Carrier Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Carrier Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. North America Carrier Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. North America Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 93. North America Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 94. North America Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 95. North America Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 96. North America Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 97. North America Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. North America Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 99. North America Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 100. North America Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Latin America Carrier Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Latin America Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 103. Latin America Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. Latin America Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 105. Latin America Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 106. Latin America Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 107. Latin America Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Latin America Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 109. Latin America Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 110. Latin America Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Europe Carrier Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Europe Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 113. Europe Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 114. Europe Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 115. Europe Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 116. Europe Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 117. Europe Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Europe Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 119. Europe Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 120. Europe Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Middle East Carrier Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Middle East Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 123. Middle East Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 124. Middle East Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 125. Middle East Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 126. Middle East Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 127. Middle East Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Middle East Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 129. Middle East Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 130. Middle East Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Africa Carrier Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Africa Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 133. Africa Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 134. Africa Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 135. Africa Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 136. Africa Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 137. Africa Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Africa Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 139. Africa Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 140. Africa Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Global Carrier Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. ASEAN Carrier Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. ASEAN Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 144. ASEAN Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 145. ASEAN Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 146. ASEAN Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 147. ASEAN Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 148. ASEAN Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. ASEAN Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 150. ASEAN Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 151. ASEAN Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. GCC Carrier Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. GCC Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 154. GCC Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 155. GCC Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 156. GCC Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 157. GCC Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 158. GCC Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. GCC Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 160. GCC Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 161. GCC Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. European Union Carrier Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. European Union Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 164. European Union Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. European Union Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 166. European Union Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 167. European Union Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 168. European Union Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. European Union Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 170. European Union Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 171. European Union Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. BRICS Carrier Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. BRICS Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 174. BRICS Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 175. BRICS Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 176. BRICS Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 177. BRICS Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 178. BRICS Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. BRICS Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 180. BRICS Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 181. BRICS Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. G7 Carrier Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. G7 Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 184. G7 Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 185. G7 Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 186. G7 Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 187. G7 Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 188. G7 Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. G7 Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 190. G7 Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 191. G7 Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. NATO Carrier Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. NATO Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 194. NATO Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 195. NATO Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 196. NATO Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 197. NATO Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 198. NATO Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. NATO Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 200. NATO Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 201. NATO Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Global Carrier Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 203. United States Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 204. United States Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 205. United States Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 206. United States Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 207. United States Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 208. United States Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 209. United States Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. United States Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 211. United States Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 212. United States Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Canada Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 214. Canada Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 215. Canada Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. Canada Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 217. Canada Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 218. Canada Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 219. Canada Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Canada Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 221. Canada Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 222. Canada Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Mexico Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 224. Mexico Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 225. Mexico Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. Mexico Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 227. Mexico Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 228. Mexico Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 229. Mexico Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Mexico Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 231. Mexico Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 232. Mexico Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Brazil Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 234. Brazil Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 235. Brazil Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 236. Brazil Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 237. Brazil Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 238. Brazil Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 239. Brazil Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Brazil Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 241. Brazil Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 242. Brazil Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. United Kingdom Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 244. United Kingdom Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 245. United Kingdom Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 246. United Kingdom Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 247. United Kingdom Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 248. United Kingdom Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 249. United Kingdom Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. United Kingdom Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 251. United Kingdom Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 252. United Kingdom Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Germany Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 254. Germany Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 255. Germany Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. Germany Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 257. Germany Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 258. Germany Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 259. Germany Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Germany Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 261. Germany Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 262. Germany Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. France Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 264. France Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 265. France Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. France Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 267. France Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 268. France Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 269. France Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. France Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 271. France Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 272. France Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Russia Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 274. Russia Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 275. Russia Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 276. Russia Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 277. Russia Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 278. Russia Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 279. Russia Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Russia Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 281. Russia Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 282. Russia Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Italy Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 284. Italy Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 285. Italy Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 286. Italy Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 287. Italy Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 288. Italy Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 289. Italy Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Italy Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 291. Italy Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 292. Italy Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. Spain Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 294. Spain Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 295. Spain Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 296. Spain Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 297. Spain Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 298. Spain Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 299. Spain Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. Spain Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 301. Spain Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 302. Spain Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. China Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 304. China Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 305. China Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 306. China Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 307. China Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 308. China Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 309. China Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 310. China Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 311. China Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 312. China Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. India Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 314. India Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 315. India Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 316. India Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 317. India Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 318. India Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 319. India Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 320. India Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 321. India Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 322. India Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Japan Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 324. Japan Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 325. Japan Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 326. Japan Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 327. Japan Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 328. Japan Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 329. Japan Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. Japan Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 331. Japan Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 332. Japan Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. Australia Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 334. Australia Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 335. Australia Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 336. Australia Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 337. Australia Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 338. Australia Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 339. Australia Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 340. Australia Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 341. Australia Carrier Screening Market Size, by Assisted Reproductive Technology (ART), 2017-2032 (USD Million)
TABLE 342. Australia Carrier Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 343. South Korea Carrier Screening Market Size, 2017-2032 (USD Million)
TABLE 344. South Korea Carrier Screening Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 345. South Korea Carrier Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 346. South Korea Carrier Screening Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 347. South Korea Carrier Screening Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 348. South Korea Carrier Screening Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 349. South Korea Carrier Screening Market Size, by Application, 2017-2032 (USD Million)
TABLE 350. South Korea Carrier Screening Market Size, by Reproductive Planning, 2017-2032 (USD Million)
TABLE 351. South Korea Carrier Screening Market Size, by A

Companies Mentioned

  • 23Andme Inc.
  • Abbott Laboratories
  • Ambry Genetics Corporation by Konica Minolta, Inc.
  • Asper Biogene
  • Autogenomics Inc. by Prescient Medicine Holdings Inc.
  • BGI Genomics Co., Ltd.
  • Biora Therapeutics, Inc.
  • CENTOGENE N.V.
  • Danaher Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Fulgent Genetics, Inc.
  • Gene by Gene, Ltd. by myDNA Inc.
  • GeneDx Holdings Corp.
  • Illumina Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Luminex Corporation by DiaSorin Company
  • MedGenome Labs Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • OPKO Health, Inc.
  • Otogenetics Corporation
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • TRUE HEALTH LABS

Table Information

Report AttributeDetails
No. of Pages191
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.49 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.97 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Carrier Screening Market Size, Share, Trends and Forecast by Type, Medical Condition, Technology, End User, and Region, 2026-2034 - Product Image

Carrier Screening Market Size, Share, Trends and Forecast by Type, Medical Condition, Technology, End User, and Region, 2026-2034

  • Report
  • 145 Pages
  • Global
From
Global Carrier Screening Market Size, Share & Industry Analysis Report by Type, Technology, End-use, Medical Conditions, Regional Outlook and Forecast, 2026-2033 - Product Image

Global Carrier Screening Market Size, Share & Industry Analysis Report by Type, Technology, End-use, Medical Conditions, Regional Outlook and Forecast, 2026-2033

  • Report
  • 677 Pages
  • Global
From
Carrier Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Carrier Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Carrier Screening Market Size, Share & Trends Analysis Report by Medical Conditions (Spinal Muscular Atrophy, Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease), Type, Technology, End Use, and Region with Growth Forecasts, 2026-2033 - Product Image

Carrier Screening Market Size, Share & Trends Analysis Report by Medical Conditions (Spinal Muscular Atrophy, Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease), Type, Technology, End Use, and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Carrier Screening - Global Strategic Business Report - Product Image

Carrier Screening - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From

About the Carrier Screening Market

The Carrier Screening market within the context of Genomics is a rapidly growing field that focuses on the detection of genetic mutations that can cause inherited diseases. Carrier Screening tests are used to identify individuals who are carriers of a genetic mutation, even if they do not show any symptoms of the disease. This type of testing is often used to identify potential risks for couples planning to have children, as well as for individuals who have a family history of a particular genetic disorder. Carrier Screening tests are typically performed using a variety of methods, including next-generation sequencing, microarray-based testing, and Sanger sequencing. These tests can be used to detect a wide range of genetic mutations, including those associated with cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. Some companies in the Carrier Screening market include Illumina, Myriad Genetics, Invitae, Counsyl, and GeneDx. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.